As of Jan 23
| -0.15 / -4.11%|
The 4 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 9.00, with a high estimate of 14.00 and a low estimate of 4.00. The median estimate represents a +157.14% increase from the last price of 3.50.
The current consensus among 6 polled investment analysts is to Buy stock in Sangamo Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.